BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer | MicrobiomeTrials← Back to trialsNCT07135271
BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2027-11
Enrollment target: 346 participants Other microbiome trials you might be interested in
AdenocarcinomaProstate CancerNeoplasmsCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type
Background:
Prostate cancer is the second most common cause of cancer-related death among men in the United States. Ear…
Bethesda, United StatesEst. completion Jun 15, 2027
Metastatic Prostate AdenocarcinomaOligometastatic Prostate Carcinoma
Prostate Adenocarcinoma
Recurrent Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8
This phase II trial studies the side effects of radiation therapy \[hypofractionated proton beam radiation therapy (PBRT…
Rochester, United StatesEst. completion Nov 22, 2025